Insiders Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 06:11:56 2024-06-13 am EDT			5-day change	1st Jan Change
987 ^DKK	-0.27%		+1.67%	+41.76%

Jun. 12	Novo Nordisk, Eli Lilly's Weight-Loss Drugs Coverage Dropped by Blue Cross Blue Shield of Michigan	MT
Jun. 12	Global markets live: Apple, Oracle, Amazon, Boeing, Tesla...

Adocia appoints Director of Operations	Jun. 04	CF
Novo Nordisk CEO: Demand for Wegovy outstrips supply	May. 02	MT
Germany's Evotec appoints Christian Wojczewski as CEO	Apr. 23	RE
Kasim Kutay, CEO of Novo Holdings: Catalent purchase marks new era of acquisitions	Mar. 12	MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly...	Mar. 07
WeightWatchers shares drop as Oprah Winfrey decides to exit board	Feb. 29	RE
Novo Nordisk CEO Jorgensen: Demand will outstrip supply for years to come	Feb. 07	MT
Jorgensen, CEO of Novo Nordisk: €10bn investment to meet demand for its weight loss drugs	Jan. 31	MT
Evotec says it promptly reported share trades withheld by former CEO	Jan. 22	RE
Kasim Kutay, CEO of Novo Holdings: Acquisition Offensive	Jan. 19	MT
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!	Nov. 27	MT
Lars Fruergaard Jorgensen, CEO of Novo Nordisk: dose limitation to continue until 2024	Nov. 02	MT
Novo Says Wegovy Is Growth Driver in US	Nov. 02	MT
Recordati, Zdravkovic vice president R&D and Sabia new CMO	23-10-16	AN
Novo Nordisk Halts Ozempic Study	23-10-11	MT
INTERVIEW - PepsiCo CFO Hugh Johnston: Ozempic has no impact on sales	23-10-10	MT
BP Chair Helge Lund Won't Become New Chief Executive	23-09-15	MT
BP Chairman Withdraws from Consideration as Next CEO	23-09-15	MT
Novo-appointed director steps down from ConvaTec board	23-09-08	AN
Novo CEO on Ozempic, Wegovy Demand, Acquisition Strategy	23-09-01	MT